Bristol-Myers Squibb to Take Part in Leerink Partners Immuno-Oncology Roundtable Conference
September 22 2016 - 9:38AM
Business Wire
Bristol-Myers Squibb Company (NYSE:BMY) will take part in
Leerink Partners Immuno-Oncology Roundtable Conference on Thursday,
September 29, 2016, in New York. Fouad Namouni, senior vice
president, Head of Oncology, will answer questions about the
company at 3:00 p.m. EDT.
Investors and the general public are invited to listen to a live
webcast of the session at http://investor.bms.com. An archived
edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us
at BMS.com or follow us on LinkedIn, Twitter,
YouTube and Facebook.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160922005741/en/
Bristol-Myers Squibb CompanyMedia:Ken Dominski,
609-252-5251ken.dominski@bms.comorInvestors:Tim Power,
609-252-7509timothy.power@bms.comorBill Szablewski,
609-252-5894william.szablewski@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Sep 2023 to Sep 2024